DHFR and malaria: TS use has recently been shown to protect against malaria in adults [3] and children [4] in Uganda, but it has not been clear if continued protection will be seen with increasing prevalence of mutations in the target enzymes dhfr and dhps that limit anti-malarial treatment efficacy of the related anti-folate SP [17-20].